Funder
Cancer Prevention and Research Institute of Texas
Common Fund
Publisher
Springer Science and Business Media LLC
Reference236 articles.
1. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391(6669), 806–811. https://doi.org/10.1038/35888
2. Wang, J., & Barr, M. M. (2005). RNA interference in Caenorhabditis elegans. Methods in Enzymology, 392, 36–55. https://doi.org/10.1016/S0076-6879(04)92003-4
3. Tatiparti, K., Sau, S., Kashaw, S. K., & Iyer, A. K. (2017). siRNA delivery strategies: A comprehensive review of recent developments. Nanomaterials (Basel, Switzerland), 7(4), 77. https://doi.org/10.3390/nano7040077
4. Resnier, P., Montier, T., Mathieu, V., Benoit, J.-P., & Passirani, C. (2013). A review of the current status of siRNA nanomedicines in the treatment of cancer. Biomaterials, 34(27), 6429–6443. https://doi.org/10.1016/j.biomaterials.2013.04.060
5. Gavrilov, K., & Saltzman, W. M. (2012). Therapeutic siRNA: Principles, challenges, and strategies. Yale Journal of Biology and Medicine, 85(2), 187–200.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献